jbm > Volume 23(4); 2016 > Article
Kwon, Ha, and Yoo: Health-related Quality of Life in Accordance with Fracture History and Comorbidities in Korean Patients with Osteoporosis



The purpose of this study was to explore health-related quality of life (HRQOL) among Korean patients with osteoporosis and to measure the impact of fractures and comorbidity on their quality of life (QOL) using the Korean National Health and Nutrition Examination Survey (KNHANES) data with a nationwide representativeness.


This study was based on 4-year-data obtained from the KNHANES 2008 to 2011. Osteoporosis was diagnosed in 2,078 survey participants according to their bone mineral density measurements using dual energy X-ray absorptiometry. According to the World Health Organization study group, T-scores at or above -1.0 are considered normal, those between -1.0 and -2.5 as osteopenia, and those at or below -2.5 as osteoporosis The EuroQol five-dimensional questionnaire (EQ-5D) index score was used to assess the QOL.


Of 2,078 patients diagnosed with osteoporosis, fractures were found to occur at 11.02%. Wrist fracture was the most frequent, affecting 4.52% of the patients, with a significantly different prevalence among men and women (P<0.001). The overall EQ-5D index score was 0.84±0.01 among patients with osteoporosis. With the exception of cancer, the EQ-5D index score were significantly lower for those having osteoarthritis, rheumatoid arthritis, hypertension, diabetes, chronic obstructive pulmonary disease and cardiovascular events compared to those without the related diseases.


We found that low health utility was associated with previous spine fracture and comorbidities in patients with osteoporosis. In particular, the number of fracture experiences greatly deteriorated the HRQOL in patients with osteoporosis. Thus, prevention of secondary fractures and chronic care model for comorbidities should be a priority for osteoporosis management in order to improve HRQOL.


Osteoporosis is one of common musculoskeletal diseases in elderly populations. Osteoporosis accompanied by osteoporotic fractures is notorious health problems and cause factors that degenerates quality of life (QOL) such as high mortality, decreased activity, and serious socioeconomic burden.[1,2,3] Although the mortality rate after osteoporotic fractures is either decreasing or maintaining a steady trend, residual disability after a fracture is still remains a major concern.[2,3,4]
Previous researches have focused on health-related QOL (HRQOL) in osteoporosis because increasing life expectancy and economic status among elderly populations cause them to divert their attention towards QOL, rather than mere survival.[5,6,7,8,9,10,11,12] It was found that osteoporosis and osteoporotic fractures have a negative impact on HRQOL. However, reduction of QOL in osteoporotic fracture is depending on with type of fractures such as vertebrae, hip, wrist, and other anatomical sites, the characteristics of the study participants, and types of reported studies.[5,6,7,8,9,10,11,12,13,14,15,16,17]
In Korea, although researches on HQROL associated with various other diseases are available,[18,19,20,21] those related to osteoporosis and osteoporotic fractures are few.[18,19] Therefore, we designed to explore HRQOL among Korean patients with osteoporosis and to measure the impact of fractures and comorbidity on their QOL using the Korean National Health and Nutrition Examination Survey (KNHANES) data with a nationwide representativeness.


1. Participants

This study was based on data from the 2008 to 2011 KNHANES, which was conducted by the Korea Ministry of Health and Welfare. The KNHANES is a nationwide representative cross-sectional survey for the Korean population with a clustered, multistage, stratified, and rolling sampling design. It consists of three sections: a health interview, a health examination, and a dietary survey. The participant's general information on health is obtained through household interviews on health. First, we collected data of 9,473 participants from July 2008 through May 2011 who were eligible to the bone mineral density (BMD) screening. The BMD screening was exerted only on men 50 years of age or older and women with menopause during 2008 to 2011. Among them, 2,078 patients who were diagnosed with osteoporosis were selected for this study.

2. Health examination survey

A health questionnaire was used to obtain information on age, gender, education level, insurance type, smoking status (current, ex-smoker, non-smoker), alcohol intake (heavy drinker, drinker, non-drinker), and walking days per week (yes or no). In terms of health behaviors, walking activities were represented as walking days per week. Heavy drinking was defined as having 5 or more drinks in one sitting in a day for 5 or more days in the past 30 days.[20] Body weight and height were measured in light clothing with no shoes, and body mass index (BMI) was calculated as weight (kg) divided by height squared (m2). Information regarding comorbidities, including: osteoarthritis (OA), rheumatoid arthritis (RA), hypertension (HTN), diabetes mellitus (DM), chronic obstructive pulmonary disease (COPD), cardiovascular (CV) events as potential confounding factors were examined through the health interview survey. Here, COPD was determined when the forced expiratory volume in 1 second (FEV1) divided by forced vital capacity was less than 0.7.[21]

3. Measurement of BMD and diagnosis for osteoporosis

BMD (g/cm2) at the lumbar spine, femoral neck, and total proximal femur were measured by dual energy X-ray absorptiometry (DXA; Hologic Inc., Bedford, MA, USA). According to the WHO study group, the diagnosis of osteoporosis is based on T-score thresholds. T-scores at or above -1.0 are considered normal, those between -1.0 and -2.5 as osteopenia, and those at or below -2.5 as osteoporosis.[22]

4. Fracture detection in personal histories

Fracture events were recorded using a standardized self-administered questionnaire. Fractures clearly caused by high-trauma events were excluded. High-trauma events included motor vehicle accidents, violence, and falls from more than the standing height of the individual. We included fracture events at only six sites (vertebra, hip, wrist, humerus, clavicle, and ribs). In addition, historical height loss, which was calculated as the difference between the subject's current measured height and self-reported recalled tallest height, of 4.0 cm or more was regarded as indicative of a prevalent vertebral fracture.[23,24,25]

5. HRQOL measures

HRQOL was evaluated using the EuroQol five-dimensional (EQ-5D) questionnaire, which generates assessment scores across five dimensions of health, namely, mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.Responses in each dimension were divided into three categories; no problem, moderate problem, or extreme problem. Average scores of the EQ-5D index were calculated to assess HRQOL, which is a preference-based health status index.[26,27,28]
HRQOL should be interpreted with caution because HRQOL has socially and culturally dependent characteristics.[29] Since the preference weights of Koreans are quite different from those of Caucasians, we used Korean specific preference weight to generate EQ-5D index scores.[28] Average scores of the EQ-5D index ranged from -0.17 to 1, where 1 indicates no problem in any of the five dimensions, zero indicates death, and negative values indicate health statuses worse than death. In addition, respondents assessed their health statuses using a visual analogue scale (VAS), which ranged from 0 (worst imaginable health state) to 100 (best imaginable health state).[30]

6. Statistical analysis

The average value of the EQ-5D index was calculated to investigate the QOL among patients with osteoporosis by using a South Korean specific tariff based on the time-trade-off method.[28] The types of fractures experienced, number of fractures were considered in the calculation of the EQ-5D index score in order to examine how seriously fracture experiences (e.g. lesion of fractures, number of fractures) could affect their QOL. Also we considered comorbidity as one of critical factors contributing to the QOL. Given the age of prevalent population of osteoporosis, this study considered HTN, DM, depressive disorder, cancer, RA, OA, and CV events such as stroke, myocardial infarction and angina, and COPD as comorbidity. Statistical differences were tested with t-test or Chi-square (χ2) using PROC SURVEYFREQ or PROC SURVEYMEANS. SAS version 9.4 (SAS Inc., Cary, NC, USA) was used for analysis.

7. Ethics statement

This study's protocol for performing an analysis of the 2008 to 2011 KNHANES data was reviewed and approved by the Institutional Review Board (Approval No. 2008-04 EXP-01-C, 2009-01CON-03-C, 2010-02CON-21-C, and 2011-02CON-06-C) of the Korea Centers for Disease Control and Prevention (KCDC). Informed consent was obtained from all of the participants when the 2008, 2009, 2010, and 2011 KNHANES were conducted. All of the data were downloaded from the official website of the KNHANES (http://knhanes.cdc.go.kr/). These data are open to the public after completion of a designated registration process for access.


1. Population characteristics

A total of 2,078 osteoporosis patients (328 men and 1,750 women) who had their T-scores at or below -2.5 were selected. Table 1 shows the general characteristics of these patients. Eighty-four percent of the study population were women with an average age of 69.60±0.30 years. Among them, 99.0% were naturally menopaused. Education level (P<0.0001) and insurance type (P=0.0018) revealed significant differences between men and women. T-scores in spine (-2.70 vs. -2.89) and femur (-2.15 vs. -2.60) were significantly lower in women than in men. BMI calculated as weight (kg) divided by height squared (m2) showed a significant difference between men and women (P<0.0001). Vitamin D level was significantly lower in women (P=0.0015). Walking activities did not differ between men and women while smoking habits and alcohol consumptions did differ significantly between men and women (P<0.0001).
The salient points were the rate of previous diagnoses with osteoporosis was only 26.18% (544/2,078) among the osteoporosis population, and the current treatment rate was 44.12% (240/544) among those already diagnosed.

2. Incidence of previous fractures

Fractures among osteoporosis patients were found to occur at 11.02%. Wrist fracture was the most frequent, at 4.52%, with a significantly different incidence among men and women (P<0.001). Next, spine fracture showed a incidence of 2.84%, followed by hip fracture at 0.87% (Table 2).
A majority of the osteoporosis patients (88.98%) reported that they had no fractures. It was found that 10.30% of the study population had fractures once, and 0.72% reported that they had experienced fractures twice or more.

3. EQ-5D scores in osteoporosis

The overall EQ-5D index score was 0.84±0.01 among patients with osteoporosis. Compared to the score of general population (0.95±0.001), this value showed lower QOL among osteoporosis patients. Men scored higher in the EQ-5D score than women (0.87 vs. 0.83 respectively, P=0.0033).
Their QOL may differ when it is accompanied by fractures and comorbidities including OA, HTN, DM, COPD, and CV events.
Figure 1 showed the scores of EQ-5D of those who had osteoporotic fractures or comorbidity compared with those of general population and patients with osteoporosis. As subgrouping osteoporosis patients by lesion of fractures and whether or not having comorbidities, EQ-5D scores were calculated. It can be inferred that having twice or more fractures mostly deteriorated the QOL according to Figure 1A.
When it comes to comorbidity, OA and CV events showed greatly lowered scores of HRQOL while cancer did not have significantly lower scores.
Table 3 shows the EQ-5D index scores at each osteoporotic health state with statistical significances. Patients with fracture experiences showed lower EQ-5D scores (0.81±0.02) than those with no fractures (0.84±0.01). However, only vertebral fractures showed a significantly lower QOL score (0.72±0.04) than having no vertebral fractures (0.84±0.01; P=0.0016).
Hip fractures negatively impacted on the QOL among osteoporosis patients but with no significant difference (0.78±0.04 vs. 0.84±0.01). Other fractures had a marginal significance (P=0.0849).
HRQOL among patients with comorbidities (Fig. 1B and Table 3) were negatively impacted than HRQOL among those without comorbidities (P<0.0001). With the exception of cancer, the EQ-5D index score were significantly lower for those having OA (0.75±0.01), RA (0.80±0.02), HTN (0.80±0.01), DM (0.80±0.02), COPD (0.80±0.01), and CV events (0.74±0.02) compared to those without the related diseases. Depression demonstrated a lower value in the EQ-5D compared to having no depression (P=0.081).


This study examined HRQOL among patients with osteoporosis and osteoporotic fractures using nationwide survey data in South Korea. Our results demonstrated that having vertebral fractures, number of fractures experienced negatively affected HRQOL of osteoporosis patients.
The decrease of QOL is depending on the characteristics of the study participants, types of reported studies, number of fractures, and the type of fractures.[5,6,7,8,9,10,11,12,13,14,15,16,17] Many studies reported a negative relationship between HRQOL and osteoporotic fracture. Several studies reported that a history of fracture was affecting the health status of postmenopausal women.[7,31,32] Hagino et al.[9] performed a prospective observational study for sequential change during one year in QOL for patients with osteoporotic fractures including hip, spine, and wrist. The decrease in HRQOL was the most serious in patients with hip fractures followed by spine fractures. However, HRQOL in patients with wrist fractures recovered back to nearly preinjury status 6 months after the injury.
Although vertebral fracture had impacted the HRQOL scores, having fracture experiences twice or more was found to have greatly deteriorated the EQ-5D scores in this study. This implies that the prevention of secondary fractures is crucial to maintaining the QOL among osteoporosis patients.[ 13,32,33]
Some studies reported the importance of comorbidity in its effects on HRQOL in patients with osteoporosis.[31,34,35,36,37,38] Bianchi et al.[31] performed a case-control study and reported that chronic diseases such as pain and depressed mood were negatively correlated with HRQOL in osteoporotic women. Salaffi et al.[37] performed an evaluation of effect of HRQOL in patients with osteoporosis using 234 women with vertebral fractures and 244 asymptomatic women. They reported that comorbidities (the simultaneous presence of one or more health conditions in a patient with a defined index condition) was an important contributor to the reduced HRQOL. Guillemin et al.[38] performed HRQOL among 7,897 European and United States women with osteoporosis in a large international study. They reported that young age, low BMI, previous vertebral fracture, increased number of comorbidities, high fear of falling and depression were associated with reduced HRQOL. These findings correspond with our study. We found that osteoporotic fractures and comorbidity such as CV events, RA, OA and COPD were associated with reduced HRQOL.
This study has several limitations. The incidence of fractures relied on patients' reports without verification using radiographic findings. However, in our experience, most patients who experienced fractures tended to remember their history of fractures. However, our study will be informative for health professionals and decision makers.
In conclusion, this study of HRQOL using nationwide survey database provides evidence that a low health utility depends on whether or not having previous spine fracture or comorbidities in patients with osteoporosis. Above all, the number of fracture experiences greatly deteriorated the HRQOL in patients with osteoporosis. Thus, prevention of secondary fractures and chronic care model for comorbidities should be a priority for osteoporosis management in order to improve QOL.


This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HC15C1189).

No potential conflict of interest relevant to this article was reported.


1. Lee SR, Ha YC, Kang H, et al. Morbidity and mortality in Jeju residents over 50-years of age with hip fracture with mean 6-year follow-up: a prospective cohort study. J Korean Med Sci 2013;28:1089-1094.
crossref pmid pmc
2. Choi HJ, Shin CS, Ha YC, et al. Burden of osteoporosis in adults in Korea: a national health insurance database study. J Bone Miner Metab 2012;30:54-58.
crossref pmid pdf
3. Yi H, Ha YC, Lee YK, et al. National healthcare budget impact analysis of the treatment for osteoporosis and fractures in Korea. J Bone Metab 2013;20:17-23.
crossref pmid pmc
4. Ha YC, Kim TY, Lee A, et al. Current trends and future projections of hip fracture in South Korea using nationwide claims data. Osteoporos Int 2016;27:2603-2609.
crossref pmid pdf
5. Al-Sari UA, Tobias J, Clark E. Health-related quality of life in older people with osteoporotic vertebral fractures: a systematic review and meta-analysis. Osteoporos Int 2016;27:2891-2900.
crossref pmid pdf
6. Begerow B, Pfeifer M, Pospeschill M, et al. Time since vertebral fracture: an important variable concerning quality of life in patients with postmenopausal osteoporosis. Osteoporos Int 1999;10:26-33.
crossref pmid pdf
7. Dhillon V, Hurst N, Hannan J, et al. Association of low general health status, measured prospectively by Euroqol EQ5D, with osteoporosis, independent of a history of prior fracture. Osteoporos Int 2005;16:483-489.
crossref pmid pdf
8. Fechtenbaum J, Cropet C, Kolta S, et al. The severity of vertebral fractures and health-related quality of life in osteoporotic postmenopausal women. Osteoporos Int 2005;16:2175-2179.
crossref pmid pdf
9. Hagino H, Nakamura T, Fujiwara S, et al. Sequential change in quality of life for patients with incident clinical fractures: a prospective study. Osteoporos Int 2009;20:695-702.
crossref pmid pdf
10. Lips P, van Schoor NM. Quality of life in patients with osteoporosis. Osteoporos Int 2005;16:447-455.
crossref pmid pdf
11. Martin AR, Sornay-Rendu E, Chandler JM, et al. The impact of osteoporosis on quality-of-life: the OFELY cohort. Bone 2002;31:32-36.
crossref pmid
12. Madureira MM, Ciconelli RM, Pereira RM. Quality of life measurements in patients with osteoporosis and fractures. Clinics (Sao Paulo) 2012;67:1315-1320.
crossref pmid pmc pdf
13. Kanis JA, Minne WH, Meunier PJ, et al. Quality of life and vertebral osteoporosis. Osteoporos Int 1992;2:161-163.
crossref pmid pdf
14. Adachi JD, Ioannidis G, Olszynski WP, et al. The impact of incident vertebral and non-vertebral fractures on health related quality of life in postmenopausal women. BMC Musculoskelet Disord 2002;3:11
crossref pmid pmc pdf
15. Silverman SL, Cranney A. Quality of life measurement in osteoporosis. J Rheumatol 1997;24:1218-1221.
16. Papaioannou A, Kennedy CC, Ioannidis G, et al. Determinants of health-related quality of life in women with vertebral fractures. Osteoporos Int 2006;17:355-363.
crossref pmid pdf
17. Adachi JD, Ioannidis G, Pickard L, et al. The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 2003;14:895-904.
crossref pmid pdf
18. Jun HJ, Kim KJ, Lee JS, et al. Association between osteoporotic fractures and quality of life based on the Korean Community Health Survey of 2010. J Phys Ther Sci 2015;27:3325-3328.
crossref pmid pmc
19. Lee JH, Lee YH, Moon SH. Association between bone mineral density and clinical consequences: cross-sectional study of Korean postmenopausal women in an orthopaedic outpatient clinic. J Korean Med Sci 2014;29:1152-1160.
crossref pmid pmc
20. Center for Behavioral Health Statistics and Quality. Behavioral health trends in the United States: Results from the 2014 national survey on drug use and health 2015;cited by 2015 September 30. Available from: http://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014.pdf.

21. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of COPD 2001;cited by 2016 August 17. Available from: www.goldcopd.com.

22. WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994;843:1-129.
23. Ettinger B, Black DM, Nevitt MC, et al. Contribution of vertebral deformities to chronic back pain and disability. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1992;7:449-456.
crossref pmid
24. Kleerekoper M, Nelson DA, Peterson EL, et al. Outcome variables in osteoporosis trials. Bone 1992;13(Suppl 1):S29-S34.
crossref pmid
25. Siminoski K, Jiang G, Adachi JD, et al. Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures. Osteoporos Int 2005;16:403-410.
crossref pmid pdf
26. Kim SH, Ahn J, Ock M, et al. The EQ-5D-5L valuation study in Korea. Qual Life Res 2016;25:1845-1852.
crossref pmid pdf
27. Kim SH, Jo MW, Lee JW, et al. Validity and reliability of EQ-5D-3L for breast cancer patients in Korea. Health Qual Life Outcomes 2015;13:203
crossref pmid pmc
28. Lee YK, Nam HS, Chuang LH, et al. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states. Value Health 2009;12:1187-1193.
crossref pmid
29. Saxena S, Carlson D, Billington R. The WHO quality of life assessment instrument (WHOQOL-Bref): the importance of its items for cross-cultural research. Qual Life Res 2001;10:711-721.
crossref pmid
30. Brooks R. EuroQol: the current state of play. Health Policy 1996;37:53-72.
crossref pmid
31. Bianchi ML, Orsini MR, Saraifoger S, et al. Quality of life in post-menopausal osteoporosis. Health Qual Life Outcomes 2005;3:78
crossref pmid pmc
32. Romagnoli E, Carnevale V, Nofroni I, et al. Quality of life in ambulatory postmenopausal women: the impact of reduced bone mineral density and subclinical vertebral fractures. Osteoporos Int 2004;15:975-980.
crossref pmid pdf
33. Yoh K, Tanaka K, Ishikawa A, et al. Health-related quality of life (HRQOL) in Japanese osteoporotic patients and its improvement by elcatonin treatment. J Bone Miner Metab 2005;23:167-173.
crossref pmid pdf
34. Starfield B. Threads and yarns: weaving the tapestry of comorbidity. Ann Fam Med 2006;4:101-103.
crossref pmid pmc
35. Fortin M, Bravo G, Hudon C, et al. Relationship between multimorbidity and health-related quality of life of patients in primary care. Qual Life Res 2006;15:83-91.
crossref pmid pdf
36. Fortin M, Lapointe L, Hudon C, et al. Multimorbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes 2004;2:51
crossref pmid pmc
37. Salaffi F, Cimmino MA, Malavolta N, et al. The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study. J Rheumatol 2007;34:1551-1560.
38. Guillemin F, Martinez L, Calvert M, et al. Fear of falling, fracture history, and comorbidities are associated with health-related quality of life among European and US women with osteoporosis in a large international study. Osteoporos Int 2013;24:3001-3010.
crossref pmid pdf
Fig. 1

Health-related quality of life scores in accordance with fracture history and comorbidity. (A) EuroQol five-dimensional questionnaire (EQ-5D) and fracture sites. (B) EQ-5D and comorbidities. OP, osteoporosis; OA, osteoarthritis; RA, rheumatoid arthritis; HTN, hypertension; DM, diabetes mellitus; COPD, chronic obstructive pulmonary disease; CV events, cardiovascular events.

Table 1

Basic characteristics of the study population


The data was presented as mean±standard deviation or number (%).

BSO, bilateral salpingo-oophorectomy; NHI, national health insurance; BMI, body mass index; NA, not available; NS, not significant at 5% of significance level.

Table 2

Incidence of previous fractures among osteoporosis patients (%)


NS, not significant at 5% of significance level.

Table 3

Un-adjusted EuroQol five-dimensional questionnaire scores in accordance with fracture aspects and comorbidities


The data was presented as mean±standard deviation.

OA, osteoarthritis; RA, rheumatoid arthritis; HTN, hypertension; DM, diabetes mellitus; COPD, chronic obstructive pulmonary disease; CV events, cardiovascular events; NS, not significant at 5% of significance level.


Browse all articles >

Editorial Office
#1001, Hyundai Kirim Officetel, 42 Seocho-daero 78-gil, Seocho-gu, Seoul 06626, Korea
Tel: +82-2-3473-2231    Fax: +82-70-4156-2230    E-mail: editors.jbm@gmail.com                

Copyright © 2024 by The Korean Society for Bone and Mineral Research.

Developed in M2PI

Close layer
prev next